Mesa Laboratories (Mesa Laboratories) Change In Working Capital : $-0.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Change In Working Capital?

Mesa Laboratories's change in working capital for the quarter that ended in Dec. 2023 was $-0.1 Mil.

Mesa Laboratories's change in working capital for the fiscal year that ended in Mar. 2023 was $-17.1 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Mesa Laboratories Change In Working Capital Historical Data

The historical data trend for Mesa Laboratories's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Change In Working Capital Chart

Mesa Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Working Capital

Get a 7-Day Free Trial

7.89

-3.14

5.25

-7.19

-17.11

Mesa Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															-4.10	2.01	-1.13	-1.36	-0.10

Mesa Laboratories Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.6 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Mesa Laboratories Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesa Laboratories (Mesa Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 West Sixth Avenue, Lakewood, CO, USA, 80228

Website

https://www.mesalabs.com

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.

Executives

Brian David Archbold	officer: SVP of Continuous Improvement	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder	director	C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens	officer: COO	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys	officer: VP Finance, CFO	MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall	director	1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin	director	380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny	director	ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia	officer: SVP Commercial Operations	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/	director	12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan	officer: VP Sales & Marketing	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly	director
Shiraz Shabanali Ladiwala	director	C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer	director	12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft	director	12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez	director	12100 6TH AVENUE, LAKEWOOD CO 80228